To examine the effect of the constitutive IRE1 signaling observed in breast cancer cells, IRE1 RNase activity was blocked by addition of MKC8866 and the outcome on cell proliferation/viability was assessed (Fig. 2d, e, Supplementary Fig. 1a, b). The gene discussed is ERN1; the disease is breast cancer.